Head-to-head study of ribociclib and letrozole vs the best current therapies
Latest Information Update: 30 Mar 2023
At a glance
- Drugs Letrozole (Primary) ; Ribociclib (Primary)
- Indications Ovarian cancer
- Focus Registrational; Therapeutic Use
- 30 Mar 2023 According to a Mount Sinai Health System media release, this work can lead to an FDA approval for this combination.
- 30 Mar 2023 New trial record